Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
index medicus (6) 6
female (5) 5
hiv infections - drug therapy (5) 5
male (5) 5
mortality (5) 5
anti-hiv agents - administration & dosage (4) 4
antiviral agents (4) 4
cd4 lymphocyte count (4) 4
drug administration schedule (4) 4
hiv (4) 4
abridged index medicus (3) 3
adult (3) 3
aids (3) 3
cardiovascular disease (3) 3
dosage and administration (3) 3
drug therapy (3) 3
hiv infections - immunology (3) 3
hiv infections - mortality (3) 3
hiv infections - virology (3) 3
infectious diseases (3) 3
middle aged (3) 3
risk (3) 3
treatment outcome (3) 3
adults (2) 2
aids-related opportunistic infections (2) 2
aids-related opportunistic infections - mortality (2) 2
anti-hiv agents (2) 2
antiretroviral therapy (2) 2
antiretrovirals (2) 2
blood pressure (2) 2
data collection (2) 2
death (2) 2
digital libraries (2) 2
digital systems (2) 2
disease risk (2) 2
drug use (2) 2
follow-up studies (2) 2
health outcomes (2) 2
hiv - genetics (2) 2
hiv - immunology (2) 2
hiv infection (2) 2
hiv infections (2) 2
hiv infections - complications (2) 2
hiv/aids (2) 2
human immunodeficiency virus (2) 2
hypertension (2) 2
individuals (2) 2
infections (2) 2
kaplan-meier estimate (2) 2
medicine (2) 2
medicine, general & internal (2) 2
opportunistic infections (2) 2
patient outcomes (2) 2
prospective studies (2) 2
research (2) 2
risk factors (2) 2
rna (2) 2
rna, viral - blood (2) 2
sex factors (2) 2
studies (2) 2
therapy (2) 2
usage (2) 2
560306 - chemicals metabolism & toxicology- man- (1) 1
abstracts (1) 1
abundance (1) 1
acquired immune deficiency syndrome (1) 1
acquired immune deficiency syndrome--aids (1) 1
adolescent (1) 1
adolescents (1) 1
african continental ancestry group (1) 1
age factors (1) 1
age groups (1) 1
aged (1) 1
aids diseases (1) 1
aids-related opportunistic infections - epidemiology (1) 1
aids-related opportunistic infections - etiology (1) 1
aids-related opportunistic infections - immunology (1) 1
alcohol drinkers (1) 1
alcohol use (1) 1
alkaline earth metals (1) 1
analysis (1) 1
analysis of variance (1) 1
anthropometric data (1) 1
anti-hiv agents - adverse effects (1) 1
anti-hiv agents - therapeutic use (1) 1
antiinflammatory properties (1) 1
antiretroviral drugs (1) 1
antiretroviral therapy, highly active (1) 1
antivirals (1) 1
apoa-i (1) 1
apolipoprotein a-i - biosynthesis (1) 1
apolipoprotein a-i - blood (1) 1
apolipoprotein a-i - drug effects (1) 1
apolipoproteins (1) 1
art periods (1) 1
art therapy (1) 1
arts (1) 1
association (1) 1
atherosclerosis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study
by Mocroft, A and Lundgren, J.D and Ross, M and Law, M and Reiss, P and Kirk, O and Smith, C and Wentworth, D and Neuhaus, J and Fux, C.A and Moranne, O and Morlat, P and Johnson, M.A and Ryom, L and Burger, D.M and et al and Royal Free Hosp Clin Cohort and INSIGHT Study Grp and DAD Study Grp and SMART Study Grp and ESPRIT Study Grp and D:A:D study group and Royal Free Hospital Clinic Cohort and SMART study group and INSIGHT study group and ESPRIT study group and D:A:D study group, the Royal Free Hospital Clinic Cohort, and the INSIGHT, SMART, and ESPRIT study groups
Plos Medicine, ISSN 1549-1676, 2015, Volume 12, Issue 3, pp. e1001809 - e1001809
BACKGROUND: Chronic kidney disease (CKD) is a major health issue for HIV-positive individuals, associated with increased morbidity and mortality. Development... 
INDIVIDUALS | GLOMERULAR-FILTRATION-RATE | MEDICINE, GENERAL & INTERNAL | POSITIVE PERSONS | PROTEINURIA | ANTIRETROVIRAL THERAPY | ASSOCIATION | STAGE RENAL-DISEASE | LIFE EXPECTANCY | EXPOSURE | PREDICTION | Kidney - drug effects | Prospective Studies | Age Factors | Kidney - pathology | Renal Insufficiency, Chronic - etiology | Risk Assessment | Comorbidity | HIV Seropositivity - complications | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Male | Risk | CD4 Lymphocyte Count | Incidence | Renal Insufficiency, Chronic - epidemiology | HIV | Clinical Decision-Making | HIV Infections - complications | Sex Factors | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Index Medicus | Life Sciences | Human health and pathology | Santé publique et épidémiologie | Infectious diseases | Urology and Nephrology | Hypertension | Antiretroviral drugs | Mortality | Cardiovascular disease | Infections | Studies | Hepatitis | Data collection | Human immunodeficiency virus | Diabetes | Kidney diseases | Drug use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Major Clinical Outcomes in Antìretroviral Therapy (ART)-Naive Participants and in Those Not Receiving ART at Baseline in the SMART Study
by Emery, Sean and Neuhaus, Jacqueline A and Phillips, Andrew N and Babiker, Abdel and Cohen, Calvin J and Gatell, Jose M and Girard, Pierre-Marie and Grund, Birgit and Law, Matthew and Losso, Marcelo H and Palfreeman, Adrian and Wood, Robin and Gordin, F and Finley, E and Dietz, D and Chesson, C and Vjecha, M and Standridge, B and Schmetter, B and Grue, L and Willoughby, M and Demers, A and Lundgren, J.D and Phillips, A and Dragsted, U.B and Jensen, K.B and Fau, A and Borup, L and Pearson, M and Jansson, P.O and Jensen, B.G and Benfield, T.L and Darbyshire, J.H and Babiker, A.G and Palfreeman, A.J and Fleck, S.L and Collaco-Moraes, Y and Cordwell, B and Dodds, W and van Hooff, F and Wyzydrag, L and Cooper, D.A and Drummond, F.M and Connor, S.A and Satchell, C.S and Gunn, S and Oka, S and Delfino, M.A and Merlin, K and McGinley, C and Neaton, J.D and Bartsch, G and Duchene, A and George, M and Harri-Harrison, M and Hogan, C and Krum, E and Larson, G and Miller, C and Nelson, R and Neuhaus, J and Roediger, M.P and Schultz, T and Thackeray, L and Prineas, R and Campbell, C and Perez, G and Lifson, A and Duprez, D and Hoy, J and Lahart, C and Perlman, D and Price, R and Rhame, F and Sampson, J and Worley, J and Rein, Board M and Dersimonian, R and Brody, B.A and Daar, E.S and Dubler, N.N and Fleming, T.R and Freeman, D.J and Kahn, J.P and Kim, K.M and Medoff, G and Modlin, J.F and Moellering, R and Murray, B.E and Pick, B and Robb, M.L and Scharfstein, D.O and Sugarman, J and Tsiatis, A and Tuazon, C and Zoloth, L and Klingman, K and Lehrman, S and Lazovski, J and Belloso, W.H and ... and SMART Study Grp and Strategies for Management of Antiretroviral Therapy (SMART) Study Group and The Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2008, Volume 197, Issue 8, pp. 1133 - 1144
Background. The SMART study randomized 5472 human immunodeficiency virus (HIV)-infected patients with CD4⁺ cell counts >350 cells/µL to intermittent... 
HIV/AIDS | Antiretrovirals | Art therapy | Health outcomes | HIV | RNA | Antivirals | Disease risk | AIDS | Random allocation | Arts | INDIVIDUALS | MORTALITY | COUNTS | INFECTIOUS DISEASES | SYSTEMIC-LUPUS-ERYTHEMATOSUS | HIV-INFECTION | MYOCARDIAL-INFARCTION | ERA | RISK | Drug Administration Schedule | AIDS-Related Opportunistic Infections - immunology | HIV Infections - virology | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | CD4 Lymphocyte Count | HIV - immunology | Anti-HIV Agents - administration & dosage | HIV Infections - immunology | AIDS-Related Opportunistic Infections - mortality | Adult | Female | HIV Infections - drug therapy | HIV Infections - mortality | Cohort Studies | Antiviral agents | Usage | Dosage and administration | Drug therapy | HIV infection | Patient outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Inferior Clinical Outcome of the CD4⁺ Cell Count-Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4⁺ Cell Counts and HIV RNA Levels during Follow-Up
by Lundgren, Jens D and Babiker, Abdel and El-Sadr, Wafaa and Emery, Sean and Grund, Birgit and Neaton, James D and Neuhaus, Jacquie and Phillips, Andrew N and Gordin, F and Finley, E and Dietz, D and Chesson, C and Vjecha, M and Standridge, B and Schmetter, B and Grue, L and Willoughby, M and Demers, A and Phillips, A and Dragsted, U.B and Jensen, K.B and Fau, A and Borup, L and Pearson, M and Jansson, P.O and Jensen, B.G and Benfield, T.L and Darbyshire, J.H and Babiker, A.G and Palfreeman, A.J and Fleck, S.L and Collaco-Moraes, Y and Cordwell, B and Dodds, W and van Hoff, F and Wazydrag, L and Cooper, D.A and Drummond, F.M and Connor, S.A and Satchell, C.S and Gunn, S and Oka, S and Delfino, M.A and Merlin, K and McGinley, C and Duchene, A and Harrison, M and George, M and Hogan, C and Krum, E and Larson, G and Miller, C and Nelson, R and Roediger, M.P and Schultz, T and Thackeray, L and Prineas, R and Campbell, C and Perez, G and Lifson, A and Duprez, D and Hoy, J and Lahart, C and Perlman, D and Price, R and Rhame, F and Sampson, J and Worley, J and Rein, M and Dersimonian, R and Brody, B.A and Daar, E.S and Dubler, N.N and Fleming, T.R and Freeman, D.J and Kahn, J.P and Kim, K.M and Medoff, G and Modlin, J.F and Moellering, R and Murray, B.E and Pick, B and Robb, M.L and Scharfstein, D.O and Sugarman, J and Tsiatis, A and Tuazon, C and Zoloth, L and Klingman, K and Lehrman, S and Lazovski, J and Belloso, W.H and Losso, M.H and Benetucci, J.A and Aquilia, S and Bittar, V and Bogdanowicz, E.P and Cahn, P.E and Casiró, A.D and Cassetti, I and ... and SMART Study Grp and Strategies for Management of Antiretroviral Therapy (SMART) Study Group and The Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2008, Volume 197, Issue 8, pp. 1145 - 1155
Background and methods. The SMART study compared 2 strategies for using antiretroviral therapy-drug conservation (DC) and viral suppression (VS)-in 5472 human... 
HIV/AIDS | Antiretrovirals | Health outcomes | HIV | RNA | Mortality | Disease risk | AIDS | Opportunistic behavior | Art periods | MORTALITY | INFECTIOUS DISEASES | GASTROINTESTINAL-TRACT | ADULTS | OPPORTUNISTIC INFECTIONS | RANDOMIZED-TRIAL | MICROBIOLOGY | DEATH | IMMUNOLOGY | EUROSIDA | THERAPY | DISEASE | Drug Administration Schedule | HIV Infections - virology | Humans | Proportional Hazards Models | RNA, Viral - blood | Treatment Outcome | CD4 Lymphocyte Count | HIV - immunology | Anti-HIV Agents - administration & dosage | HIV Infections - immunology | AIDS-Related Opportunistic Infections - epidemiology | AIDS-Related Opportunistic Infections - mortality | HIV - genetics | HIV Infections - drug therapy | HIV Infections - mortality | Antiviral agents | Patient outcomes | CD4 lymphocytes | Physiological aspects | Dosage and administration | Research | HIV (Viruses) | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights